Postoperative infliximab and elemental diet combination in a case with diffuse, extensive jejunoileal Crohn’s disease

被引：0
|
作者：
Saori Matsuda
Takuya Bamba
Shingo Sohma
Takayuki Yamamoto
机构：
[1] Yokkaichi Social Insurance Hospital,Inflammatory Bowel Disease Center
来源：
International Journal of Colorectal Disease | 2014年 / 29卷
关键词：
Infliximab; Enteral Nutrition; Mesalazine; Short Bowel Syndrome; Elemental Diet;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：265 / 266
页数：1
相关论文
共 50 条
  • [31] LOCAL INJECTION OF INFLIXIMAB IN THE POSTOPERATIVE SYMPTOMATIC RECURRENCE OF CROHN'S DISEASE
    Andreoli, A.
    Cosintino, R.
    Mangiarotti, R.
    Tesi, A.
    Prantera, C.
    DIGESTIVE AND LIVER DISEASE, 2008, 40 : S12 - S12
  • [32] Postoperative Infliximab Is Not Associated with An Increase in Adverse Events in Crohn’s Disease
    Miguel Regueiro
    Sandra El-Hachem
    Kevin E. Kip
    Wolfgang Schraut
    Leonard Baidoo
    Andrew Watson
    Jason Swoger
    Marc Schwartz
    Arthur Barrie
    Marilyn Pesci
    David Binion
    Digestive Diseases and Sciences, 2011, 56 : 3610 - 3615
  • [33] Postoperative Infliximab Is Not Associated with An Increase in Adverse Events in Crohn's Disease
    Regueiro, Miguel
    El-Hachem, Sandra
    Kip, Kevin E.
    Schraut, Wolfgang
    Baidoo, Leonard
    Watson, Andrew
    Swoger, Jason
    Schwartz, Marc
    Barrie, Arthur
    Pesci, Marilyn
    Binion, David
    DIGESTIVE DISEASES AND SCIENCES, 2011, 56 (12) : 3610 - 3615
  • [34] Infliximab treatment of an esophagobronchial fistula in a patient with extensive Crohn's disease of the esophagus
    Ho, IK
    Guarino, DP
    Pertsovskiy, Y
    Cerulli, MA
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2002, 34 (04) : 488 - 489
  • [35] Combination therapy of infliximab and azathioprine reduces disease progression in Crohn's disease
    Din, S
    Cochrane, CJ
    Noble, CL
    Satsangi, J
    Arnott, IDR
    GUT, 2006, 55 : A78 - A79
  • [36] Combination therapy of infliximab & azathioprine prevents disease progression in Crohn's disease
    Din, Shahida
    Cochrane, Claire J.
    Noble, Colin L.
    Satsangi, Jack
    Arnott, Ian D.
    GASTROENTEROLOGY, 2006, 130 (04) : A651 - A651
  • [37] Combination therapy of infliximab and azathioprine reduces disease progression in Crohn's disease
    Din, S.
    Cochrane, C. J.
    Noble, C. L.
    Satsangi, J.
    Arnott, I. D. R.
    INFLAMMATORY BOWEL DISEASES, 2008, 14 (01) : 143 - 145
  • [38] Efficacy of "half elemental diet" as a maintenance therapy for Crohn's disease: Crohn's disease half elemental diet study in Sendai (CHESS): A randomized controlled trial
    Takagi, Sho
    Utsunomiya, Kyoko
    Kuriyama, Shinichi
    Yokoyama, Hiroshi
    Takahashi, Shuichiro
    Iwabuchi, Masahiro
    Takahashi, Hiroki
    Takahashi, Seiichi
    Kinouchi, Yoshitaka
    Hiwatashi, Nobuo
    Funayama, Yuji
    Sasaki, Iwao
    Tsuji, Ichiro
    Shimosegawa, Tooru
    GASTROENTEROLOGY, 2006, 130 (04) : A484 - A484
  • [39] Use of immunomodulators in combination with infliximab in Crohn's disease: time for a reappraisal?
    Chapman, Thomas P.
    Ahmad, Tariq
    Satsangi, Jack
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2024, 9 (05): : 402 - 405
  • [40] Infliximab in Crohn's disease
    Sáez, LR
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2004, 96 (06) : 359 - 363
12345